Lung disease targets and uses thereof
AssigneeCelera Corporation
InventorsBruno Domon, Elizabeth Joseloff, Aiqun Li, Tao He
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
Claims5
A method of diagnosing lung cancer in an individual, the method comprising detecting an elevated level of COMT protein in a sample from the individual as compared to a control COMT protein level of an individual who does not have lung cancer, wherein the elevated level of COMT protein indicates that said individual has lung cancer.
Dependencies are inferred from the claim text.